Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Objective To examine whether rosiglitazone alters gene expression of some key genes involved in mitochondrial biogenesis and oxidative capacity in skeletal muscle of type 2 diabetic patients, and whether this is associated with alterations in skeletal muscle oxidative capacity and lipid content.Design measured in muscle biopsies obtained from diabetic patients, before and after 8 weeks of rosiglitazone treatment, and matched controls. Furthermore, whole-body insulin sensitivity and substrate utilization were assessed.Subjects Ten obese type 2 diabetic patients and 10 obese normoglycemic controls matched for age and BMI.Methods Gene expression and mitochondrial protein content of complexes I-V of the respiratory chain were measured by quantitative polymerase chain reaction and Western blotting, respectively. Histochemical staining was used to quantify lipid accumulation and complex II succinate dehydrogenase (SDH) activity. Insulin sensitivity and substrate utilization were measured during a hyperinsulinemic-euglycemic clamp with indirect calorimetry.Results Skeletal-muscle mRNA of PGC-1 alpha and PPAR beta/delta--but not of other genes involved in glucose, fat and oxidative metabolism--was significantly lower in diabetic patients (P<0.01). Rosiglitazone significantly increased PGC-1 alpha ( approximately 2.2-fold, P<0.01) and PPAR beta/delta ( approximately 2.6-fold, P<0.01), in parallel with an increase in insulin sensitivity, SDH activity and metabolic flexibility (P<0.01). Surprisingly, none of the measured mitochondrial proteins was reduced in type 2 diabetic patients, nor affected by rosiglitazone treatment. No alterations were seen in muscular fat accumulation upon treatment.Conclusion These results suggest that the insulin-sensitizing effect of rosiglitazone may involve an effect on muscular oxidative capacity, via PGC-1 alpha and PPAR beta/delta, independent of mitochondrial protein content and/or changes in intramyocellular lipid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions
Higuchi, R., Fockler, C., Dollinger, G., & Watson, R. (1993) · Nature Biotechnology · doi:10.1038/nbt0993-1026 · Cited by 2,159
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Diet, muscle glycogen and physical performance.
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1967.tb03720.x · Cited by 1,740
Table of nonprotein respiratory quotient: an update.
Péronnet, F., & Massicotte, D. (1991) · PubMed · Cited by 1,458
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194
Cited by
PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
Regulation of mitochondrial biogenesis
Jornayvaz, F. R., & Shulman, G. I. (2010) · Essays in Biochemistry · doi:10.1042/bse0470069 · Cited by 1,119
“Rosiglitazone treatment for 8 weeks also increased expression of PGC-1α and activity of oxidative enzymes in skeletal muscle of patients with Type 2 diabetes [57].”
BackgroundMechanisms of obesity-associated insulin resistance: many choices on the menu
Qatanani, M., & Lazar, M. A. (2007) · Genes & Development · doi:10.1101/gad.1550907 · Cited by 778
“Finally, activation or induction of PGC-1 has recently been shown to be associated with improved mitochondrial function as well as increased insulin sensitivity in both animals and humans (Lagouge et al. 2006; Mensink et al. 2007).”
BackgroundSivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle
Chinsomboon, J., Ruas, J., Gupta, R. K., Thom, R., Shoag, J., Rowe, G. C., Sawada, N., Raghuram, S., & Arany, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909131106 · Cited by 379
Meex, R. C. R., Schrauwen-Hinderling, V. B., Moonen-Kornips, E., Schaart, G., Mensink, M., Phielix, E., van de Weijer, T., Sels, J.-P., Schrauwen, P., & Hesselink, M. K. C. (2010) · Diabetes · doi:10.2337/db09-1322 · Cited by 355
Self-citationSergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
“…PGC 1α expression in type 2 diabetic individuals with the effect of this drug on insulin sensitivity being coupled with enhanced muscular oxidative capacity and restoration of oxidative metabolism transcriptome towards the values typical of metabolic healthy individuals (Mensink et al., 2007).”
BackgroundWenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.006 · Cited by 297
RetractedRitov, V. B., Menshikova, E. V., Azuma, K., Wood, R., Toledo, F. G. S., Goodpaster, B. H., Ruderman, N. B., & Kelley, D. E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00317.2009 · Cited by 283
E2F transcription factor-1 regulates oxidative metabolism
Blanchet, E., Annicotte, J.-S., Lagarrigue, S., Aguilar, V., Clapé, C., Chavey, C., Fritz, V., Casas, F., Apparailly, F., Auwerx, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2309 · Cited by 271
Mitochondrial dysfunction and lipotoxicity
Schrauwen, P., Schrauwen-Hinderling, V., Hoeks, J., & Hesselink, M. K. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.011 · Cited by 268
Self-citationZhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
Hesselink, M. K. C., Schrauwen-Hinderling, V., & Schrauwen, P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.104 · Cited by 242
Self-citationHyperglycemia Predicts Persistently Lower Muscle Strength With Aging
Kalyani, R. R., Metter, E. J., Egan, J., Golden, S. H., & Ferrucci, L. (2015) · Diabetes Care · doi:10.2337/dc14-1166 · Cited by 236
Russell, A. P., Wada, S., Vergani, L., Hock, M. B., Lamon, S., Léger, B., Ushida, T., Cartoni, R., Wadley, G. D., Hespel, P., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.015 · Cited by 225
“A down regulation of PGC-1α is observed in conditions associatedwithmitochondrial dysfunction such as diabetes (Mensink et al., 2007) and ageing (Short et al., 2003) aswell as in skeletalmuscle atrophy, such as uremia, denervation and cancer cachexia (Sandri et al., 2006).”
Self-citationBenton, C. R., Nickerson, J. G., Lally, J., Han, X.-X., Holloway, G. P., Glatz, J. F. C., Luiken, J. J. F. P., Graham, T. E., Heikkila, J. J., & Bonen, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704332200 · Cited by 214
In vitro and in vivo antioxidant activity of polyphenols extracted from black highland barley
Shen, Y., Zhang, H., Cheng, L., Wang, L., Qian, H., & Qi, X. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.08.083 · Cited by 209
Type 2 Diabetes Mellitus and Skeletal Muscle Metabolic Function
Phielix, E., & Mensink, M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.01.020 · Cited by 198
“In addition, PGC-1α expression restored after treatment with the anti-diabetic agent Rosiglitazone together with an improvement in muscular insulin sensitivity, and an improved metabolic function [34].”
BackgroundResultInfluentialSelf-citationPPARγ inhibits NF-κB-dependent transcriptional activation in skeletal muscle
Remels, A. H. V., Langen, R. C. J., Gosker, H. R., Russell, A. P., Spaapen, F., Voncken, J. W., Schrauwen, P., & Schols, A. M. W. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90632.2008 · Cited by 184
Self-citationSkeletal muscle “mitochondrial deficiency” does not mediate insulin resistance
Holloszy, J. O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26717c · Cited by 175
Sarcopenia and frailty in older patients with diabetes mellitus
Umegaki, H. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12688 · Cited by 173
Insulin Resistance and Mitochondrial Dysfunction
González-Franquesa, A., & Patti, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_25 · Cited by 176
A Reservoir of Brown Adipocyte Progenitors in Human Skeletal Muscle
Crisan, M., Casteilla, L., Lehr, L., Carmona, M., Paoloni-Giacobino, A., Yap, S., Sun, B., Léger, B., Logar, A., Pénicaud, L., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0325 · Cited by 172
Self-citationWang, Y., Feng, W., Xue, W., Tan, Y., Hein, D. W., Li, X.-K., & Cai, L. (2009) · Diabetes · doi:10.2337/db08-1697 · Cited by 167
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin
Farshbaf, M. J., & Alviña, K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.649929 · Cited by 159
“For example, PGC1α expression in skeletal muscle is reduced in humans and diabetic models in rodents (Jove et al., 2004; Mensink et al., 2007).”
BackgroundZoladz, J. A., Majerczak, J., Żeligowska, E., Mencel, J., Jaskólski, A., Jaskólska, A., & Marusiak, J. (2014) · PubMed · Cited by 158
The Role of Mitochondria in the Pathophysiology of Skeletal Muscle Insulin Resistance
Pagel-Langenickel, I., Bao, J., Pang, L., & Sack, M. N. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0003 · Cited by 154
“subjects (234), albeit without induction of mitochondrial”
Jornayvaz, F. R., Samuel, V. T., & Shulman, G. I. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104726 · Cited by 126
Muruganandan, S., Parlee, S. D., Rourke, J. L., Ernst, M. C., Goralski, K. B., & Sinal, C. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220491 · Cited by 128
Meng, Q., Qi, X., Fu, Y., Chen, Q., Cheng, P., Yu, X., Sun, X., Wu, J., Li, W., Zhang, Q., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112326 · Cited by 145
Salem, A. F., Whitaker‐Menezes, D., Howell, A., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.22376 · Cited by 142
Wang, C., Wang, C., & Wei, Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05625.x · Cited by 119
Mitochondrial Dysfunction in Type 2 Diabetes and Obesity
Højlund, K., Mogensen, M., Sahlin, K., & Beck-Nielsen, H. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.006 · Cited by 135
Joseph, A.-M., Joanisse, D. R., Baillot, R. G., & Hood, D. A. (2012) · Experimental Diabetes Research · doi:10.1155/2012/642038 · Cited by 117
Pagel-Langenickel, I., Bao, J., Joseph, J. J., Schwartz, D. R., Mantell, B. S., Xu, X., Raghavachari, N., & Sack, M. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800842200 · Cited by 124
van Herpen, N. A., Schrauwen-Hinderling, V. B., Schaart, G., Mensink, R. P., & Schrauwen, P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2243 · Cited by 124
Self-citationTaub, P. R., Ramirez‐Sanchez, I., Ciaraldi, T. P., Perkins, G., Murphy, A. N., Naviaux, R., Hogan, M., Maisel, A. S., Henry, R. R., Ceballos, G., et al. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00357.x · Cited by 122
TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia?
Remels, A. H. V., Gosker, H. R., Schrauwen, P., Hommelberg, P. P. H., Sliwinski, P., Polkey, M., Galdiz, J., Wouters, E. F. M., Langen, R. C. J., & Schols, A. M. W. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-150714 · Cited by 122
Self-citationMinnaard, R., Schrauwen, P., Schaart, G., Jorgensen, J. A., Lenaers, E., Mensink, M., & Hesselink, M. K. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0352 · Cited by 104
Self-citationLessard, S. J., Rivas, D. A., Chen, Z.-P., Bonen, A., Febbraio, M. A., Reeder, D. W., Kemp, B. E., Yaspelkis, B. B., & Hawley, J. A. (2007) · Diabetes · doi:10.2337/db06-1065 · Cited by 103
Metabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 97
“In fact, PGC-1 expression is greatly educed in the skeletal muscle of diabetic patients and in anial models of diabetes [72,73], and a high concentration of ree fatty acids in plasma leads to insulin resistance in muscles.”
BackgroundSkov, V., Glintborg, D., Knudsen, S., Tan, Q., Jensen, T., Kruse, T. A., Beck-Nielsen, H., & Højlund, K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002466 · Cited by 84
López-Pedrera, C., Barbarroja, N., Jiménez, Y., Collantes‐Estévez, E., Aguirre, M. A., & Cuadrado, M. J. (2016) · Rheumatology · doi:10.1093/rheumatology/kew054 · Cited by 87
Cameron, R. B., Beeson, C., & Schnellmann, R. G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00669 · Cited by 84
Pérez‐Sánchez, C., Aguirre, M. A., Ruiz‐Limón, P., Ábalos-Aguilera, M. C., Jiménez, Y., de la Rosa, I. A., Rodríguez‐Ariza, A., Fernández-del-Río, L., González-Reyes, J. A., Segui, P., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309225 · Cited by 83
Fujimaki, S., & Kuwabara, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102147 · Cited by 84
“Obese T2DM patients exhibited decreased expression of PPARδ in skeletal muscle [54].”
BackgroundDumas, J., Simard, G., Flamment, M., Ducluzeau, P., & Ritz, P. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.02.002 · Cited by 80
García‐Ruíz, I., Solís‐Muñoz, P., Fernández-Moreira, D., Muñoz‐Yagüe, T., & Solis-Herruzo, J. A. (2013) · BMC Biology · doi:10.1186/1741-7007-11-88 · Cited by 67
“demonstrated that rosiglitazone increased PGC1α gene expression in patients with type 2 diabetes mellitus [40].”
BackgroundRuiz‐Limón, P., Barbarroja, N., Pérez‐Sánchez, C., Aguirre, M. A., Bertolaccini, M. L., Khamashta, M. A., Rodríguez‐Ariza, A., Almadén, Y., Segui, P., Khraiwesh, H. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204351 · Cited by 66
Insulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0251-x · Cited by 64
Rosiglitazone Improves Stallion Sperm Motility, ATP Content, and Mitochondrial Function
Swegen, A., Lambourne, S. R., Aitken, R. J., & Gibb, Z. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.142687 · Cited by 64
Hoeks, J., Briedé, J. J., de Vogel, J., Schaart, G., Nabben, M., Moonen-Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.013 · Cited by 63
Self-citationShen, W., Hao, J., Tian, C., Ren, J., Yang, L., Li, X., Luo, C., Cotma, C. W., & Liu, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002328 · Cited by 63
Jans, A., Konings, E., Goossens, G. H., Bouwman, F. G., Moors, C. C. M., Boekschoten, M. V., Afman, L. A., Müller, M. M., Mariman, E. C. M., & Blaak, E. E. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.028787 · Cited by 63
Central Fat and Peripheral Muscle
van den Borst, B., Gosker, H. R., & Schols, A. M. W. J. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1441oe · Cited by 61
“For example, decreased mitochondrial respiration has also been reported in patients with type 2 diabetes (12, 13), and the magnitude of reduced skeletal muscle peroxisome proliferator–activated receptor-g coactivator-1a (PGC-1a) gene (the master regulator of mitochondrial biogenesis) expression is comparable between n…”
BackgroundMuscular mitochondrial dysfunction and type 2 diabetes mellitus
Schrauwen-Hinderling, V. B., Roden, M., Kooi, M. E., Hesselink, M. K., & Schrauwen, P. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282f0eca9 · Cited by 57
Self-citationFrankowski, R., Kobierecki, M., Wittczak, A., Różycka-Kosmalska, M., Pietras, T., Sipowicz, K., & Kosmalski, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119677 · Cited by 58
Rocha, M., Apostolova, N., Herance, J. R., Rovira‐Llopis, S., Hernández‐Mijares, A., & Víctor, V. M. (2013) · Medicinal Research Reviews · doi:10.1002/med.21285 · Cited by 57
Naples, S. P., Borengasser, S. J., Rector, R. S., Uptergrove, G. M., Morris, E. M., Mikus, C. R., Koch, L. G., Britton, S. L., Ibdah, J. A., & Thyfault, J. P. (2010) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-139 · Cited by 54
“However, the expression of PGC-1α-controlled oxidative genes are reduced in patients with type 2 diabetes or have been shown to not change or to decrease in animals and humans placed on a HFD, respectively (Mootha et al. 2003; Patti et al. 2003; Koves et al. 2005; Sparks et al. 2005; Mensink et al. 2007).”
BackgroundNgo, D. T. M., Sverdlov, A. L., Karki, S., Macartney-Coxson, D. P., Stubbs, R. S., Farb, M. G., Carmine, B. J., Hess, D. T., Colucci, W. S., & Gokce, N. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00227.2018 · Cited by 55
Crossland, H., Constantin‐Teodosiu, D., & Greenhaff, P. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189775 · Cited by 53
Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling
Remels, A. H. V., Gosker, H. R., Bakker, J. A., Guttridge, D. C., Schols, A. M. W. J., & LANGEN, R. C. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.018 · Cited by 50
Rabøl, R., Boushel, R., Almdal, T., Hansen, C. N., Ploug, T., Haugaard, S. B., Prats, C., Madsbad, S., & Dela, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01237.x · Cited by 44
Liu, J., Zhang, W., Chuang, G. C., Hill, H. S., Tian, L., Fu, Y., Moellering, D. R., & Garvey, W. T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00663.2011 · Cited by 48
Muscle development and obesity: Is there a relationship?
Maltin, C. A. (2008) · Organogenesis · doi:10.4161/org.4.3.6312 · Cited by 48
Hausman, G., Poulos, S. P., Pringle, T. D., & Azain, M. J. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0219 · Cited by 47
Mazzatti, D. J., Smith, M. A., Oita, R. C., Lim, F.-L., White, A. J., & Reid, M. B. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00281.2007 · Cited by 41
Schrauwen-Hinderling, V. B., Mensink, M., Hesselink, M. K. C., Sels, J.-P., Kooi, M. E., & Schrauwen, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0267 · Cited by 43
Self-citationNabben, M., Shabalina, I. G., Moonen‐Kornips, E., van Beurden, D., Cannon, B., Schrauwen, P., Nedergaard, J., & Hoeks, J. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.003 · Cited by 45
Self-citationTargeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/604685 · Cited by 43
RetractedGenetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
Rat Urinary Bladder Carcinogenesis by Dual‐Acting PPAR α + γ Agonists
Oleksiewicz, M. B., Southgate, J., Iversen, L., & Egerod, F. L. (2008) · PPAR Research · doi:10.1155/2008/103167 · Cited by 40
“Further, it has been described that PPARα and PPARγ agonists may exhibit synergistic effects in cells coexpressing PPARα and PPARγ [19, 28, 53–55].”
BackgroundWang, L., Fan, H., Zhou, L., Wu, Y., Lu, H., & Luo, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.010 · Cited by 42
Traish, A. M., Abdallah, B., & Yu, G. W. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.132 · Cited by 40
“IR in T2DM is associated with reduced oxidative capacity in skeletal muscle [88, 89] as well as diminished expression of a set of nuclear genes involved in oxidative metabolism [38, 39, 90, 91] .”
BackgroundThiazolidinedione Response in Familial Lipodystrophy Patients with LMNA Mutations: A Case Series
Luedtke, A., Boschmann, M., Colpe, C., Engeli, S., Adams, F., Birkenfeld, A. L., Haufe, S., Rahn, G., Luft, F. C., Schmidt, H., et al. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0031-1301284 · Cited by 37
Amin, S. N., Hussein, U. K., Yassa, H. D., Hassan, S. S., & Rashed, L. A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26300 · Cited by 37
“These results are in line with a previous study in both humans and animals reporting lower levels of PGC-1α in skeletal muscles (Mensink et al., 2007).”
ResultAntunes, B. M., Neto, J. C. R., Batatinha, H., Franchini, É., Teixeira, A. M., & Lira, F. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-70731-6 · Cited by 35
Amirazodi, M., Mehrabi, A., Rajizadeh, M. A., Bejeshk, M. A., Esmaeilpour, K., Daryanoosh, F., & Gaeini, A. A. (2022) · PubMed Central · doi:10.22038/ijbms.2022.57780.12853 · Cited by 35
“Effects of resveratrol on AMPK (AMP activated protein kinase)-SIRT1-PGC-1α (peroxisome proliferatoractivated receptor gamma coactivator-1 alpha) pathway have also been reported (20, 21).”
BackgroundVaughan, R. A., Mermier, C. M., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0301-4 · Cited by 34
“In humans, the effect of rosiglitazone is likely a product of muscular oxidative capacity controlled through PGC-1 α, although metabolic adaptations may occur independent of mitochondrial biogenesis [63].”
BackgroundMitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 34
“Rosiglitazone, a PPARg agonist belonging to the thiazolidinedione family, given for 8 weeks to T2D patients not only improved insulin sensitivity, but also restored normal levels of muscle PGC-1a mRNA, PPARd mRNA, and succinate dehydrogenase activity (Mensink et al. 2007).”
BackgroundRelationships between Exercise, Mitochondrial Biogenesis and Type 2 Diabetes
Joseph, A.-M., & Hood, D. A. (2014) · Medicine and Sport Science · doi:10.1159/000357335 · Cited by 31
Chen, H., Xiong, L., Wang, N., Liu, X., Hu, W., Yang, Z., Jiang, Y., Zheng, G., Ouyang, K., & Wang, W. (2018) · Food & Function · doi:10.1039/c8fo00954f · Cited by 32
Kim, S.-Y., Lee, M.-S., Chang, E., Jung, S., Ko, H., Lee, E., Lee, S., Kim, C., Kim, I.-H., & Kim, Y. (2019) · Nutrients · doi:10.3390/nu11030654 · Cited by 32
Sathaye, S. S., Kaikini, A. A., Kanchan, D., & Nerurkar, U. (2017) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/phrev.phrev_41_16 · Cited by 32
Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice
Wang, H., Kuusela, S., Rinnankoski‐Tuikka, R., Dumont, V., Bouslama, R., Ramadan, U. A., Waaler, J., Linden, A.-M., Chi, N., Krauss, S. J. K., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0573-z · Cited by 32
Targeting Mitochondria for Cardiac Protection
Hernández‐Reséndiz, S., Buelna‐Chontal, M., Correa, F., & Zazueta, C. (2013) · Current Drug Targets · doi:10.2174/1389450111314050008 · Cited by 31
Blanchet, É., Annicotte, J., Pradelli, L. A., Hugon, G., Matecki, S., Mornet, D., Rivier, F., & Fajas, L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds219 · Cited by 31
Håkansson, J., Eliasson, B., Smith, U., & Enerbäck, S. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-32 · Cited by 31
“PGC1a has been shown to be positively regulated by TZDs and suppressed during insulin resistance [16,19].”
BackgroundTzika (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000244 · Cited by 30
Ma, X., & Chen, F. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i33.10064 · Cited by 29
Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes
Wessels, B., Čiapaitė, J., van den Broek, N. M. A., Houten, S. M., Nicolay, K., & Prompers, J. J. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12388 · Cited by 29
“Rosiglitazone has been reported to enhance expression of PGC-1α in skeletal muscle [34], but this was not reflected in an increase in mitochondrial content [34,51].”
BackgroundFinn, A. V., John, M. C., Nakazawa, G., Polavarapu, R., Karmali, V., Xu, X. Y., Cheng, Q., Davis, T., Raghunathan, C., Acampado, E., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.200519 · Cited by 28
Mitochondria and endoplasmic reticulum: Targets for a better insulin sensitivity in skeletal muscle?
Boulinguiez, A., Staels, B., Duez, H., & Lancel, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.011 · Cited by 28
Yalamanchi, S., Stewart, K. J., Ji, N., Golden, S. H., Dobs, A. S., Becker, D. M., Vaidya, D. M., Kral, B. G., & Kalyani, R. R. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.026 · Cited by 26
Pathophysiology of the Metabolic Syndrome
Nolan, J. J., & O’Gorman, D. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_3 · Cited by 26
Lee, Y.-J., Jang, Y. N., Han, Y.-M., Kim, H. M., Jeong, J.-M., Son, M. J., Jin, C., Kim, H. J., & Seo, H. S. (2017) · PPAR Research · doi:10.1155/2017/3912567 · Cited by 26
“In obese patients with type 2 diabetes, rosiglitazone increased insulin sensitization through upregulation of mRNA levels of PPARδ and PGC-1α, as well as stimulation of SDH activity in skeletal muscles [49].”
BackgroundCalderón-DuPont, D., Torre-Villalvazo, I., & Díaz‐Villaseñor, A. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.021 · Cited by 25
Yin, Q., Zhang, L., Han, X., Zhang, H., Wang, F., Qin, X., Zhuang, P., & Zhang, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154000 · Cited by 25
Jans, A., Sparks, L. M., van Hees, A. M. J., Gjelstad, I. M. F., Tierney, A. C., Risérus, U., Drevon, C. A., Roche, H. M., Schrauwen, P., & Blaak, E. E. (2011) · Obesity · doi:10.1038/oby.2011.149 · Cited by 24
Self-citation
Metadata
- Authors
- Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P.
- Affiliations
- Maastricht University (NL)
- Deakin University (AU)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Mensink, M
- Venue
- International Journal of Obesity
- Published
- 2007-02-20
- Volume
- 31
- Issue
- 8
- Pages
- 1302-1310
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2114190855
- Cited by
- 160
- References
- 26
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 11
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Koninklijke Nederlandse Akademie van Wetenschappen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- rosiglitazone, type 2 diabetes, skeletal muscle, PGC-1α, PPARδ, mitochondrial biogenesis, oxidative capacity, insulin sensitivity, metabolic flexibility, succinate dehydrogenase, intramyocellular lipid, mitochondrial protein content, gene expression
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Rosiglitazone, Biopsy, Blood Glucose, Diabetes Mellitus, Type 2, Gene Expression Regulation, Heat-Shock Proteins, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Middle Aged, Mitochondria, Muscle, Obesity, Transcription Factors, Case-Control Studies, Muscle, Skeletal, Mitochondrial Proteins, Thiazolidinediones, PPAR-beta, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.